SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-148457
Filing Date
2023-05-19
Accepted
2023-05-18 19:47:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d463802ds3.htm S-3 146519
2 EX-5.1 d463802dex51.htm EX-5.1 7808
3 EX-23.1 d463802dex231.htm EX-23.1 1629
4 EX-FILING FEES d463802dexfilingfees.htm EX-FILING FEES 18252
5 GRAPHIC g463802g02p03.jpg GRAPHIC 66115
6 GRAPHIC g463802g0518052148588.jpg GRAPHIC 2308
  Complete submission text file 0001193125-23-148457.txt   269827
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272064 | Film No.: 23937630
SIC: 2836 Biological Products, (No Diagnostic Substances)